about
Breast cancer intra-tumor heterogeneityMED12 somatic mutations in fibroadenomas and phyllodes tumours of the breastHotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands.Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast.Pregnancy at early age is associated with a reduction of progesterone-responsive cells and epithelial Wnt signaling in human breast tissueCerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma.TIA-1 cytotoxic granule-associated RNA binding protein improves the prognostic performance of CD8 in mismatch repair-proficient colorectal cancerMassively parallel sequencing analysis of synchronous fibroepithelial lesions supports the concept of progression from fibroadenoma to phyllodes tumor.MAGE-A10 is a nuclear protein frequently expressed in high percentages of tumor cells in lung, skin and urothelial malignancies.Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients.Intra-tumor genetic heterogeneity and alternative driver genetic alterations in breast cancers with heterogeneous HER2 gene amplification.HIPK2 deficiency causes chromosomal instability by cytokinesis failure and increases tumorigenicityUterine adenosarcomas are mesenchymal neoplasms.Massively parallel sequencing of phyllodes tumours of the breast reveals actionable mutations, and TERT promoter hotspot mutations and TERT gene amplification as likely drivers of progressionResolving quandaries: basaloid adenoid cystic carcinoma or breast cylindroma? The role of massively parallel sequencing.A survey of DICER1 hotspot mutations in ovarian and testicular sex cord-stromal tumorsVascular endothelial growth factor A amplification in colorectal cancer is associated with reduced M1 and M2 macrophages and diminished PD-1-expressing lymphocytesGenomic landscape of adenoid cystic carcinoma of the breastGenetic alterations of triple negative breast cancer by targeted next-generation sequencing and correlation with tumor morphologyMassively Parallel Sequencing-Based Clonality Analysis of Synchronous Endometrioid Endometrial and Ovarian Carcinomas.Infiltrating epitheliosis of the breast: characterization of histological features, immunophenotype and genomic profileMicroglandular adenosis associated with triple-negative breast cancer is a neoplastic lesion of triple-negative phenotype harbouring TP53 somatic mutations.Targeted capture massively parallel sequencing analysis of LCIS and invasive lobular cancer: Repertoire of somatic genetic alterations and clonal relationshipsAre acinic cell carcinomas of the breast and salivary glands distinct diseases?The repertoire of somatic genetic alterations of acinic cell carcinomas of the breast: an exploratory, hypothesis-generating studyIntegrative genomic and transcriptomic characterization of papillary carcinomas of the breast.Genetic events in the progression of adenoid cystic carcinoma of the breast to high-grade triple-negative breast cancer.HMGA1 Expression in Human Hepatocellular Carcinoma Correlates with Poor Prognosis and Promotes Tumor Growth and Migration in in vitro Models.Genetic analysis of microglandular adenosis and acinic cell carcinomas of the breast provides evidence for the existence of a low-grade triple-negative breast neoplasia family.Preclinical evaluation of the PARP inhibitor BMN-673 for the treatment of ovarian clear cell cancerCancer-associated fibroblasts release exosomal microRNAs that dictate an aggressive phenotype in breast cancer.Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle.High mobility group A1 enhances tumorigenicity of human cholangiocarcinoma and confers resistance to therapy.RNASeq analysis reveals biological processes governing the clinical behaviour of endometrioid and serous endometrial cancersGenetic Heterogeneity in Therapy-Naïve Synchronous Primary Breast Cancers and Their Metastases.HMGA1 overexpression is associated with a particular subset of human breast carcinomas.Genetic analysis of uterine adenosarcomas and phyllodes tumors of the breast.PIKing the type and pattern of PI3K pathway mutations in endometrioid endometrial carcinomas.Whole-genome single-cell copy number profiling from formalin-fixed paraffin-embedded samplesLack of PRKD2 and PRKD3 kinase domain somatic mutations in PRKD1 wild-type classic polymorphous low-grade adenocarcinomas of the salivary gland
P50
Q27000086-530EF891-AAB6-4F08-95A2-8D99890C0996Q28260148-7BB35294-EF8B-4615-9FC9-8BB200AA3819Q30459163-29A465BA-C4E9-4753-871D-71C36AD064BCQ33579776-E20D4C23-72CB-4B64-A173-EA0C0C324D1DQ33618323-4AA3FBAD-35B9-477C-A176-DDAC22F3BAE7Q33663019-77647737-B23A-4978-AC7D-1637CDCAA895Q33778276-3F21590F-588B-4C8E-97C0-AA6C586512DBQ33915051-397A3030-06E3-49B2-A8DA-2541C867B6E3Q34196069-003F2707-DE7F-4FB6-BA8F-36FC73E4B5C8Q34376920-089F73B2-4421-4D93-BC41-A71BAA52DC8EQ35633666-EC00ACEC-9DD0-4561-B8FD-E3642CB634B6Q35832992-3D4F4FBC-D72A-4B82-A514-A3D4A252AEBEQ35848142-4625BFAC-18D8-42CF-9A47-D62E17F84FBBQ35911314-B0AA2FB0-CA68-472E-8A85-435F56191E47Q36260485-A821B06E-84F2-490C-AA46-CBA1222D44B2Q36338657-A64DCE1C-E6D4-4BBA-8D97-6F2AAFE8A188Q36344920-51E8645A-92EC-4789-975A-07123954EA52Q36366309-DF27B139-63F7-4F80-9A0B-D8DB27B81B2EQ36844915-5AF68805-95D2-4700-9418-12800771B79FQ37007851-96EE59AB-4416-4436-B918-D35FA78E9A8FQ37119308-4EE3BE75-CE73-4DFC-841D-2084F521A5BBQ37130372-A974866A-688F-449B-9EA0-DF4783AA7AC6Q37186761-52C7613E-8E2D-4693-B8A6-1E81F9CB74CAQ37220987-90CC1A41-1477-489C-BEE4-67C728634980Q37232177-4CF25487-AFBA-4F68-AA60-E95F8799E8DAQ37284899-4F0245A9-CB26-4462-8325-C72D73200E94Q37372455-E6B08C6C-9CEF-4441-B69C-50B2B7E39A69Q37415944-99B36F49-3FF1-438E-BB00-90AC364806E0Q37572813-1739359A-1B4C-4D95-BDCE-324BE27ECB9AQ37701538-8AC38C1E-2295-4704-99F4-4B716157C2B2Q37746078-C7BD0016-C2A0-4BA5-BB62-02D94E16C1C1Q38390966-A35D42FF-DE89-4DCE-A010-166B3598CC8DQ38807021-C728B513-365C-49EE-9F21-EC80880F0584Q39598461-705A4350-B23C-4C49-B034-137AC74531FBQ40269605-DD09AFA7-DF16-43FA-B010-BDC5A9EB0293Q40649343-C4B8B04D-39D4-4043-9F8A-2D93134AE8A7Q41195725-33B8ECA1-0DBC-428A-85B6-F4EA868A81D4Q41195725-3DA2EDE6-B13A-4E50-B3B3-6FD90A5CD684Q41378259-CDFC19BF-7031-4DF8-B4D1-2843C07D7CABQ41708245-A18C5989-8A51-41B1-8180-57FE5D368737
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Salvatore Piscuoglio
@ast
Salvatore Piscuoglio
@en
Salvatore Piscuoglio
@es
Salvatore Piscuoglio
@sl
type
label
Salvatore Piscuoglio
@ast
Salvatore Piscuoglio
@en
Salvatore Piscuoglio
@es
Salvatore Piscuoglio
@sl
prefLabel
Salvatore Piscuoglio
@ast
Salvatore Piscuoglio
@en
Salvatore Piscuoglio
@es
Salvatore Piscuoglio
@sl
P1053
F-9248-2014
P106
P21
P2798
P31
P3829
P3835
salvatore-piscuoglio3
P496
0000-0003-2686-2939